| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |